Akanda (AKAN) Receivables - Other (2022 - 2025)

Akanda's (AKAN) quarterly Receivables - Other came in at $1031.0 in Q4 2025, down 99.72% year-on-year from $368172.0 in Q4 2024, and down 99.72% quarter-over-quarter from $368172.0 in Q4 2024.

Akanda (AKAN) Receivables - Other (2022 - 2025) Analysis & Trends

Akanda's Receivables - Other history runs 4 years deep, the most recent figure standing at $1031.0 for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 99.72% year-over-year to $1031.0 in Q4 2025; TTM through Dec 2025 was $1031.0, a 99.72% decrease from a year earlier, with the FY2025 full-year figure at $1031.0, down 99.72% from the prior year.
  • Receivables - Other fell to $1031.0 in Q4 2025 per AKAN's latest filing, from $368172.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $424118.0 in Q4 2022 and bottomed at $1031.0 in Q4 2025.
  • The 4-year median for Receivables - Other is $228894.5 (2023), against an average of $220734.5.
  • Across the five-year window, Receivables - Other soared 310.83% in 2024 and slumped 99.72% in 2025, its largest moves.
  • Year by year, Receivables - Other stood at $424118.0 in 2022, then tumbled by 78.87% to $89617.0 in 2023, then surged by 310.83% to $368172.0 in 2024, then slumped by 99.72% to $1031.0 in 2025.
  • Per Business Quant, the three latest AKAN Receivables - Other figures stand at $1031.0 (Q4 2025), $368172.0 (Q4 2024), and $89617.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Akanda 556,353.85 556,353.85 -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,031.00
Dec 31, 2025 1,031.00
Dec 31, 2024 368,172.00
Dec 31, 2024 368,172.00
Dec 31, 2023 89,617.00
Dec 31, 2023 89,617.00
Dec 31, 2022 424,118.00
Dec 31, 2022 424,118.00